When to consider aspergillosis in dogs - Veterinary Medicine
Medicine Center
DVM Veterinary Medicine Featuring Information from:


When to consider aspergillosis in dogs
Sinonasal and disseminated aspergillosis—the two classic presentations—are caused by different Aspergillus fungi. Learn how to manage these clinically distinct infections, and find out how the prognoses for affected dogs differ between the two.


16. Mathews KG, Davidson AP, Koblik PD, et al. Comparison of topical administration of clotrimazole through surgically placed versus nonsurgically placed catheters for treatment of nasal aspergillosis in dogs: 60 cases (1990-1996). J Am Vet Med Assoc 1998;213:501-506.

17. Zonderland JL, Stork CK, Saunders JH, et al. Intranasal infusion of enilconazole for treatment of sinonasal aspergillosis in dogs. J Am Vet Med Assoc 2002;221:1421-1425.

18. Sharp NJH, Burrell MH, Sullivan M, et al. Canine nasal aspergillosis: serology and treatment with ketoconazole. J Small Anim Pract 1984;25:149-158.

19. Sharp NJH, Harvey CE, O'Brien JA. Treatment of canine nasal aspergillosis/penicilliosis with fluconazole. J Small Anim Pract 1991;32:513-516.

20. McCarthy TC. Nasal aspergillosis in a Welsh corgi puppy. Vet Med 2002;97:731.

21. Claeys S, Lefebvre JB, Schuller S, et al. Surgical treatment of canine nasal aspergillosis by rhinotomy combined with enilconazole infusion and oral itraconazole. J Small Anim Pract 2006;47:320-324.

22. Greci V, Stefanello D, Di Giancamillo M, et al. Sinonasal tumor in 3 dogs after successful topical treatment for frontal sinus aspergillosis. Can Vet J 2009;50:1191-1194.

23. Schultz RM, Johnson EG, Wisner ER, et al. Clinicopathologic and diagnostic imaging characteristics of systemic aspergillosis in 30 dogs. J Vet Intern Med 2008;22:851-859.

24. Garcia ME, Caballero J, Cruzado M, et al. The value of the determination of anti-Aspergillus IgG in the serodiagnosis of canine aspergillosis: comparison with galactomannan detection. J Vet Med B Infect Dis Vet Public Health 2001;48:743-750.

25. Odds FC, Brown AJ, Gow NA. Antifungal agents: mechanisms of action. Trends Microbiol 2003;11:272-279.

26. Kelly SE, Shaw SE, Clark WT. Long-term survival of four dogs with disseminated Aspergillus terreus infection treated with itraconazole. Aust Vet J 1995;72:311-313.

27. Morgenstern GR, Prentice AG, Prentice HG, et al. A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies. U.K. Multicentre Antifungal Prophylaxis Study Group. Br J Haematol 1999;105:901-911.

28. Ullmann AJ, Lipton JH, Vesole DH, et al. Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. N Engl J Med 2007;356:335-347.

29. Herbrecht R, Denning DW, Patterson TF, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002;347:408-415.

30. Pfaller MA, Messer SA, Hollis RJ, et al. Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program, 2000. Antimicrob Agents Chemother 2002;46:1032-1037.

31. Rosales MS, Marsella R, Kunkle G, et al .Comparison of the clinical efficacy of oral terbinafine and ketoconazole combined with cephalexin in the treatment of Malassezia dermatitis in dogs-a pilot study. Vet Dermatol 2005;16:171-176.


Click here